Wheaton™ DualFusion vials combine the best properties of glass, with the mechanical strength and the precision molding of plastic
Manufactured in a Class 7 Clean Room and E-Beam sterilized to meet USP788 for low particulate levels and USP85 for low endotoxin level for injectables Engineered to protect pharmaceutical drugs and sample formulations that are prone to cause glass delamination and that are sensitive to oxidation via the permeation of atmospheric oxygen
Using a state-of-the-art Plasma Enhanced Chemical Vapor Deposition (PECVD) Technology, an organosilicate protective layer is fused with a silica-like (SiO2 barrier) layer
These layers are fused to a Cyclic Olefin Polymer (COP) shell to form a robust covalently bonded material resulting in an inert surface
DualFusion stand-alone nested tubs can be paired with Snap Cap and Aluminum Seal closure offerings Wheaton™ DualFusion Vials are manufactured by and sold under license from SiO2 Medical Products, Inc.
USP <788>/EP 2.9.19 Particulate Matter in Injections, USP <85>/EP 2.6.1, The Bacterial Endotoxins Test and USP <71>/ EP 2.6.14 The Sterility Test, USP <660>/EP 3.2.1 Glass Containers for Pharmaceutical Use, and USP <381>/EP 3.2.9 Elastomeric Closures used in Parenteral Preparations
USP <788>/EP 2.9.19 Particulate Matter in Injections, USP <85>/EP 2.6.1, The Bacterial Endotoxins Test and USP <71>/ EP 2.6.14 The Sterility Test, USP <660>/EP 3.2.1 Glass Containers for Pharmaceutical Use, and USP <381>/EP 3.2.9 Elastomeric Closures used in Parenteral Preparations
USP <788>/EP 2.9.19 Particulate Matter in Injections, USP <85>/EP 2.6.1, The Bacterial Endotoxins Test and USP <71>/ EP 2.6.14 The Sterility Test, USP <660>/EP 3.2.1 Glass Containers for Pharmaceutical Use, and USP <381>/EP 3.2.9 Elastomeric Closures used in Parenteral Preparations